Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Azacitidine for the treatment...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

Show other versions (1)
Bibliographic Details
Main Authors: R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld
Format: Article
Language:English
Published: NIHR Journals Library 2010-05-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta14suppl1/10
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

https://doi.org/10.3310/hta14suppl1/10

Similar Items

  • Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
    by: R Edlin, et al.
    Published: (2010-05-01)
  • Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome
    by: Peter Černelč, et al.
    Published: (2012-12-01)
  • PHASE 3B STUDY DESIGN: COMPARING TREATMENT PREFERENCE BETWEEN ORAL DECITABINE/CEDAZURIDINE AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME, LOW-BLAST ACUTE MYELOID LEUKAEMIA, OR CHRONIC MYELOMONOCYTIC LEUKAEMIA
    by: A. Enjeti, et al.
    Published: (2024-01-01)
  • Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    by: Boultwood, J, et al.
    Published: (2004)
  • Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
    by: Goh, Chermaine Yu Zhen
    Published: (2021)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs